Larnocin Trademark Details

Larnocin was registered on Tuesday, May 17, 1983 and is currently owned by Pfizer Inc. under the registration number 1237988 . This mark is dead with a status of Cancelled - Section 8. The last case file activity for this mark occured 20 years ago on Saturday, February 21, 2004, according to the United State Patent & Trademark Office
Word Mark Larnocin
Status Dead Registered 710 — Cancelled - Section 8
Pfizer Inc.
235 E. 42nd St.
New York, Ny 10017
Pfizer Inc.
235 E. 42nd St.
New York, Ny 10017
Pfizer Inc.
235 E. 42nd St.
New York, Ny 10017
Serial Number 73335618
Registration Number 1237988
Status Date Saturday, February 21, 2004
Filing Date Saturday, February 21, 2004
Registration Date Tuesday, May 17, 1983
Attorney Jay K. Meadway

Correspondent

JAY K. MEADWAY
21st FLOOR
235 EAST 42nd STREET
NEW YORK, NEW YORK 10017

Case File Statements

Goods & Services Medicated Throat Lozenges for the Treatment of Sore Throats

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 018
Status 2 — Sec. 8 – Entire Registration
Status Date Saturday, February 21, 2004
First Use Anywhere Monday, August 31, 1981
First Use In Commerce Monday, August 31, 1981
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.